Both docetaxel+androgen deprivation therapy (ADT) and abiraterone acetate 1000mg/d+prednisone/prednisolone 5mg/d+ADT improved survival in patients with metastatic castration-naive prostate cancer. Their use should be offered and guided by patient's own characteristics.
European urology focus. 2018 Feb 27 [Epub ahead of print]
Zineb Hamilou, Giulia Baciarello, Karim Fizazi
Institut Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France; Centre Hospitalier de l'Université de Montréal, Montréal, Canada., Institut Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France., Institut Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. Electronic address: .